12 results on '"pancreatology"'
Search Results
2. Early Enteral Nutrition in Paediatric Acute Pancreatitis—A Review of Published Studies.
- Author
-
Bukowski, Jan Stanisław, Dembiński, Łukasz, Dziekiewicz, Marcin, and Banaszkiewicz, Aleksandra
- Abstract
Nowadays, nutrition is said to be an integral aspect of acute pancreatitis (AP) treatment. Early enteral nutrition (EEN) is safe and beneficial for patients. This was confirmed by clinical experience and can be found in guidelines on managing adults with AP. Furthermore, paediatric recommendations encourage EEN use in AP. However, paediatric guidelines are based exclusively on studies in adults. Therefore, we present a review of published studies on the time of nutritional interventions in children with AP. A search was independently conducted in April 2022 by two of the authors. Only full-text papers published in English involving children between 0–21 were considered. Only four papers met our inclusion criteria: one randomised-control trial (RCT), one prospective study with retrospective chart review, and two retrospective chart reviews. All studies supported EEN and there was no recommendation of any delay in its initiation. The results of all four papers suggested EEN with a regular, normal-fat diet. EEN is safe in children with mild or moderately severe AP and may decrease the length of hospitalisation. Unfortunately, all the conclusions are based on a small amount of heterogeneous data that are mostly retrospective. Future prospective RCTs are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Very early and early nutrition in children with pancreatitis-A randomised trial.
- Author
-
Bukowski JS, Jamer T, Kowalska-Duplaga K, Marczuk M, Stelmaszczyk-Emmel A, Banasiuk M, and Banaszkiewicz A
- Subjects
- Humans, Male, Female, Child, Child, Preschool, Prospective Studies, Adolescent, Infant, C-Reactive Protein analysis, C-Reactive Protein metabolism, Poland, Severity of Illness Index, Biomarkers blood, Lipase blood, Acute Disease, Pancreatitis blood, Cytokines blood
- Abstract
Objectives: The aim of our study was to assess the impact of the very early introduction of refeeding on the course of acute pancreatitis (AP) in children. Additionally, we evaluated the effect of nutrition on inflammatory markers, including cytokines., Methods: This prospective randomised study was conducted in three university hospitals in Poland. Patients, aged 1-18 years with AP, were randomised into two groups: A-refeeding within 24 h of hospital admission (very early), and B-refeeding at least 24 h after admission (early nutrition). The severity of AP was assessed after 48 h. The serum concentrations of four cytokines (tumour necrosis factor α [TNFα], interleukin-1β [IL-1β], interleukin-6 [IL-6] and interleukin-8 [IL-8]) and C-reactive protein, as well as the activity of amylase, lipase and aminotransferases, were measured during the first 3 days of hospitalisation., Results: A total of 94 children were recruited to participate in the study. The statistical analysis included 75 patients with mild pancreatitis: 42-group A and 33-group B. The two groups did not differ in the length of hospitalisation (p = 0.22), AP symptoms or results of laboratory tests. Analysis of cytokine levels was conducted for 64 children: 38-group A and 26-group B. We did not find a difference in concentrations of the measured cytokines, except for IL-1β on the third day of hospitalisation (p = 0.01)., Conclusions: The time of initiation of oral nutrition within 24 h (very early) or after 24 h (early) from the beginning of hospitalisation had no impact on the length of hospitalisation, concentrations of TNF-α, IL-1β, IL-6 and IL-8, activity of amylase and lipase or occurrence of symptoms in children with mild AP., (© 2024 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.)
- Published
- 2024
- Full Text
- View/download PDF
4. Editorial: Hot Topics in Pancreatology From Europe-2020
- Author
-
Gabriele Capurso, Sebastien Gaujoux, and Enrique de-Madaria
- Subjects
pancreatology ,Pancreas 2000 ,mentoring ,European pancreatic club ,future ,Medicine (General) ,R5-920 - Published
- 2021
- Full Text
- View/download PDF
5. Early Enteral Nutrition in Paediatric Acute Pancreatitis—A Review of Published Studies
- Author
-
Jan Stanisław Bukowski, Łukasz Dembiński, Marcin Dziekiewicz, and Aleksandra Banaszkiewicz
- Subjects
early enteral nutrition ,pancreatology ,paediatric acute pancreatitis ,Nutrition. Foods and food supply ,TX341-641 - Abstract
Nowadays, nutrition is said to be an integral aspect of acute pancreatitis (AP) treatment. Early enteral nutrition (EEN) is safe and beneficial for patients. This was confirmed by clinical experience and can be found in guidelines on managing adults with AP. Furthermore, paediatric recommendations encourage EEN use in AP. However, paediatric guidelines are based exclusively on studies in adults. Therefore, we present a review of published studies on the time of nutritional interventions in children with AP. A search was independently conducted in April 2022 by two of the authors. Only full-text papers published in English involving children between 0–21 were considered. Only four papers met our inclusion criteria: one randomised-control trial (RCT), one prospective study with retrospective chart review, and two retrospective chart reviews. All studies supported EEN and there was no recommendation of any delay in its initiation. The results of all four papers suggested EEN with a regular, normal-fat diet. EEN is safe in children with mild or moderately severe AP and may decrease the length of hospitalisation. Unfortunately, all the conclusions are based on a small amount of heterogeneous data that are mostly retrospective. Future prospective RCTs are needed.
- Published
- 2022
- Full Text
- View/download PDF
6. Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis
- Author
-
Dávid Németh, Dániel Pécsi, Adrienn Erős, Bálint Erőss, Péter Hegyi, Péter Jeno Hegyi, Zsolt Szakács, Alexandra Mikó, Szilárd Váncsa, and Gabriella Pár
- Subjects
medicine.medical_specialty ,acute pancreatitis ,lcsh:Medicine ,Disease ,Review ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,business.industry ,lcsh:R ,Fatty liver ,non-alcoholic fatty liver disease ,General Medicine ,Odds ratio ,Hepatology ,medicine.disease ,Confidence interval ,030220 oncology & carcinogenesis ,Meta-analysis ,hepatology ,pancreatology ,Acute pancreatitis ,fatty liver disease ,030211 gastroenterology & hepatology ,prognosis ,business ,Cohort study - Abstract
The prevalence of fatty liver disease (FLD) and that of non-alcoholic fatty liver disease (NAFLD) share some risk factors known to exacerbate the course of acute pancreatitis (AP). This meta-analysis aimed to investigate whether FLD or NAFLD carry a higher risk of untoward outcomes in AP. In accordance with PRISMA guidelines, we performed a systematic search in seven medical databases for cohort studies that compared the outcomes of AP for the presence of FLD or NAFLD, and we calculated pooled odds ratio (OR) or weighted mean difference (WMD) with 95% confidence interval (CI). We included 13 articles in our meta-analysis. AP patients with FLD were more likely to die (5.09% vs 1.89%, OR = 3.56, CI = 1.75–7.22), develop severe AP (16.33% vs 7.87%, OR = 2.67, CI = 2.01–3.56), necrotizing pancreatitis (34.83% vs 15.75%, OR = 3.08, CI = 2.44–3.90) and had longer in-hospital stay (10.8 vs 9.2 days, WMD = 1.46, OR = 0.54–2.39). Patients with NAFLD were more likely to have severe AP and longer hospital stay. Both FLD and NAFLD proved to be independent risk factors of a more severe disease course (OR = 3.68, CI = 2.16–6.29 and OR = 3.39, CI = 1.52–7.56 for moderate/ severe vs. mild AP, respectively). FLD and NAFLD worsen the outcomes of AP, which suggests that incorporating FLD or NAFLD into prognostic scoring systems of AP outcomes might improve the prediction of severity and contribute to a more individualized patient care.
- Published
- 2020
7. Improving outcomes for operable pancreatic cancer: Is access to safer surgery the problem?
- Author
-
Chang, David K., Merrett, Neil D., and Biankin, Andrew V.
- Subjects
- *
PANCREATIC cancer treatment , *OPERATIVE surgery , *GENERAL practitioners , *NIHILISM , *MORTALITY , *HEALTH outcome assessment - Abstract
Despite advances in the understanding and treatment of pancreatic cancer in the last two decades, there is a persisting nihilistic attitude among clinicians. An alarmingly high rate of under-utilization of surgical management for operable pancreatic cancer was recently reported in the USA, where more than half of patients with stage 1 operable disease and no other contraindications were not offered surgery as therapy, denying this group of patients a 20% chance of long-term survival. These data indicate that a nihilistic attitude among clinicians may be a significant and reversible cause of the persisting high mortality of patients with pancreatic cancer. This article examines the modern management of pancreatic cancer, in particular, the advances in surgical care that have reduced the mortality of pancreatectomy to almost that of colonic resection, and outlines a strategy for improving outcomes for patients with pancreatic cancer now and in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
8. The future of pancreatology: how to go where we have never been before
- Author
-
Urrutia, Raul
- Subjects
- *
MOLECULAR biology , *BIOLOGY , *CYTOLOGY , *GENOMICS - Abstract
Abstract: The current article is part of a series of manuscripts, which together serve as a never-perfect yet candid attempt to honor the remarkable scientific stature of Professor Hans Gunther Beger. The challenge posed to the author has been to meditate on the future of pancreatology. In the following paragraphs, to the exclusion of no other, we provide an approach to future discoveries in our field. This approach combines the large scope of the new biology (eg, genomics) with the analytical power of conventional, hypothesis-driven, molecular cell biology of individual laboratories to build comprehensive functional models of normal and diseased pancreatic cell populations. In addition, the potential challenges that both the size of our field and current research funding offer to scientists focused on the pancreas are discussed. It is the author’s hope that the readers will not only meditate on the reflections offered here but, when in agreement with the positions stated, will help to implement a road map that can make our scientific field better. Never forget—the lives of our patients depend on what we do. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
9. Proteomics in Pancreatic Disease.
- Author
-
Löhr, Matthias and Faissner, Ralf
- Abstract
Proteomics represents a novel methodological approach to investigate the expression of all proteins by a cell or organism in its entireness, similar to global strategies for DNA (genomics) and RNA (transcriptomics). This review focuses on the history of protein analysis, which made up the golden age of pancreatic physiology, the current methodology for proteomics (2D gel electrophoresis, mass spectrometry) and the few published experiences with proteomics in the field of pancreatology until now. Finally, potential applications of proteomics for the pancreas, in concert with other techniques, are cited. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
10. The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3.
- Author
-
Bassi, Claudio, Salvia, Roberto, Gumbs, Andrew A., Butturini, Giovanni, Falconi, Massimo, and Pederzoli, Paolo
- Subjects
TUMORS ,BLOOD plasma ,TUMOR markers ,BIOMARKERS ,DIAGNOSIS ,CYSTS (Pathology) ,ONCOLOGY - Abstract
Background. Differentiating between mucinous cystic tumors (MCTs) and serous cystic tumors (SCTs) can be a troubling diagnostic dilemma in pancreatology: when SCTs present in their macro-oligocystic form they must be resected because MCT cannot be ruled out, and some tumors considered benign are actually MCTs, which delays diagnosis and places patients at increased risk. Examination of preoperative serum tumor markers may help improve preoperative diagnosis. Materials and methods. The tumor markers CEA, Ca 19-9, Ca 125, and Ca 15-3 were examined in 157 patients with SCTs or MCTs. Results. Positive CEA marker status is an indicator of an MCT, although sensitivity is low at 17%. Using three serum tumor markers (CEA, Ca 19-9, and Ca 125), 27% of MCTs were found to have two or more markers positive, compared to none for the SCTs. Sensitivity decreases to 13% for differentiating benign MCTs from benign SCTs but specificity remains 100%. Conclusions. In the differential diagnosis of SCTs vs. MCTs no reliable serum tumor marker exists which can diagnose SCTs and spare some patients unnecessary operations. Nonetheless, positive CEA serum marker status and or the presence of more than two positive serum markers (CEA, Ca 19-9, or Ca 125) indicates the presence of an MCT and can prevent delay in diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
11. Editorial: Hot Topics in Pancreatology From Europe-2020.
- Author
-
Capurso G, Gaujoux S, and de-Madaria E
- Abstract
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a past co-authorship with the author Ed-M.
- Published
- 2021
- Full Text
- View/download PDF
12. Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis.
- Author
-
Váncsa, Szilárd, Németh, Dávid, Hegyi, Péter, Szakács, Zsolt, Hegyi, Péter Jeno, Pécsi, Dániel, Mikó, Alexandra, Erőss, Bálint, Erős, Adrienn, and Pár, Gabriella
- Subjects
- *
FATTY liver , *NECROTIZING pancreatitis , *DISEASE progression , *META-analysis , *PANCREATITIS - Abstract
The prevalence of fatty liver disease (FLD) and that of non-alcoholic fatty liver disease (NAFLD) share some risk factors known to exacerbate the course of acute pancreatitis (AP). This meta-analysis aimed to investigate whether FLD or NAFLD carry a higher risk of untoward outcomes in AP. In accordance with PRISMA guidelines, we performed a systematic search in seven medical databases for cohort studies that compared the outcomes of AP for the presence of FLD or NAFLD, and we calculated pooled odds ratio (OR) or weighted mean difference (WMD) with 95% confidence interval (CI). We included 13 articles in our meta-analysis. AP patients with FLD were more likely to die (5.09% vs 1.89%, OR = 3.56, CI = 1.75–7.22), develop severe AP (16.33% vs 7.87%, OR = 2.67, CI = 2.01–3.56), necrotizing pancreatitis (34.83% vs 15.75%, OR = 3.08, CI = 2.44–3.90) and had longer in-hospital stay (10.8 vs 9.2 days, WMD = 1.46, OR = 0.54–2.39). Patients with NAFLD were more likely to have severe AP and longer hospital stay. Both FLD and NAFLD proved to be independent risk factors of a more severe disease course (OR = 3.68, CI = 2.16–6.29 and OR = 3.39, CI = 1.52–7.56 for moderate/ severe vs. mild AP, respectively). FLD and NAFLD worsen the outcomes of AP, which suggests that incorporating FLD or NAFLD into prognostic scoring systems of AP outcomes might improve the prediction of severity and contribute to a more individualized patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.